IL148547A0 - Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions - Google Patents
Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditionsInfo
- Publication number
- IL148547A0 IL148547A0 IL14854700A IL14854700A IL148547A0 IL 148547 A0 IL148547 A0 IL 148547A0 IL 14854700 A IL14854700 A IL 14854700A IL 14854700 A IL14854700 A IL 14854700A IL 148547 A0 IL148547 A0 IL 148547A0
- Authority
- IL
- Israel
- Prior art keywords
- embryonic
- stem
- methods
- cell lines
- tissue culture
- Prior art date
Links
- 230000013020 embryo development Effects 0.000 title 1
- 230000002708 enhancing effect Effects 0.000 title 1
- 230000004077 genetic alteration Effects 0.000 title 1
- 231100000118 genetic alteration Toxicity 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000010449 nuclear transplantation Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/04—Cells produced using nuclear transfer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Psychology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Developmental Biology & Embryology (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39536899A | 1999-09-14 | 1999-09-14 | |
| PCT/US2000/025090 WO2001019977A1 (en) | 1999-09-14 | 2000-09-14 | Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL148547A0 true IL148547A0 (en) | 2002-09-12 |
Family
ID=23562752
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14854700A IL148547A0 (en) | 1999-09-14 | 2000-09-14 | Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| IL148547A IL148547A (en) | 1999-09-14 | 2002-03-06 | Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL148547A IL148547A (en) | 1999-09-14 | 2002-03-06 | Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1214404A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2003525031A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1379814A (cg-RX-API-DMAC7.html) |
| AU (1) | AU7701900A (cg-RX-API-DMAC7.html) |
| BR (1) | BR0013999A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2384413A1 (cg-RX-API-DMAC7.html) |
| IL (2) | IL148547A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA02002744A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ517609A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001019977A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7696404B2 (en) | 1996-08-19 | 2010-04-13 | Advanced Cell Technology, Inc. | Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| IL148418A0 (en) * | 1999-09-07 | 2002-09-12 | Advanced Cell Tech Inc | Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| JP2003512052A (ja) * | 1999-10-15 | 2003-04-02 | アドバンスド セル テクノロジー、インコーポレイテッド | 分化前駆細胞及び系統欠失胚性幹細胞の産生方法 |
| JP2004500066A (ja) * | 1999-12-20 | 2004-01-08 | ユニバシティ オブ マサチューセッツ、ア パブリック インスチチユーション オブ ハイアー エデュケイション オブ ザ コモンウエルス オブ マサチューセッツ、アズ リプリゼンテッド バイ イッツ ア | 異種間核移植により生成する胚あるいは幹様細胞 |
| US7221981B2 (en) | 2002-03-28 | 2007-05-22 | Northstar Neuroscience, Inc. | Electrode geometries for efficient neural stimulation |
| US10865383B2 (en) | 2011-07-12 | 2020-12-15 | Lineage Cell Therapeutics, Inc. | Methods and formulations for orthopedic cell therapy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| BR9711204A (pt) * | 1996-08-19 | 1999-08-17 | Univ Massachusetts | Linhagens de c-lulas embriÄnicas ou similares s indiferenciadas produzidas por transplante nuclear de esp-cies hibridas |
| WO1999005266A2 (en) * | 1997-07-26 | 1999-02-04 | Wisconsin Alumni Research Foundation | Trans-species nuclear transfer |
| CN1299408A (zh) * | 1998-03-02 | 2001-06-13 | 马萨诸塞大学 | 通过异种间的核移植产生的胚细胞或干细胞样细胞系 |
| JP2004500066A (ja) * | 1999-12-20 | 2004-01-08 | ユニバシティ オブ マサチューセッツ、ア パブリック インスチチユーション オブ ハイアー エデュケイション オブ ザ コモンウエルス オブ マサチューセッツ、アズ リプリゼンテッド バイ イッツ ア | 異種間核移植により生成する胚あるいは幹様細胞 |
-
2000
- 2000-09-14 NZ NZ517609A patent/NZ517609A/en unknown
- 2000-09-14 BR BR0013999-8A patent/BR0013999A/pt not_active Application Discontinuation
- 2000-09-14 MX MXPA02002744A patent/MXPA02002744A/es not_active Application Discontinuation
- 2000-09-14 EP EP00966717A patent/EP1214404A4/en not_active Withdrawn
- 2000-09-14 WO PCT/US2000/025090 patent/WO2001019977A1/en not_active Ceased
- 2000-09-14 JP JP2001523749A patent/JP2003525031A/ja active Pending
- 2000-09-14 AU AU77019/00A patent/AU7701900A/en not_active Abandoned
- 2000-09-14 IL IL14854700A patent/IL148547A0/xx unknown
- 2000-09-14 CA CA002384413A patent/CA2384413A1/en not_active Abandoned
- 2000-09-14 CN CN00814278A patent/CN1379814A/zh active Pending
-
2002
- 2002-03-06 IL IL148547A patent/IL148547A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA02002744A (es) | 2003-07-21 |
| NZ517609A (en) | 2004-02-27 |
| EP1214404A4 (en) | 2003-09-03 |
| CN1379814A (zh) | 2002-11-13 |
| IL148547A (en) | 2009-09-01 |
| WO2001019977A9 (en) | 2002-09-26 |
| EP1214404A1 (en) | 2002-06-19 |
| JP2003525031A (ja) | 2003-08-26 |
| CA2384413A1 (en) | 2001-03-22 |
| WO2001019977A1 (en) | 2001-03-22 |
| AU7701900A (en) | 2001-04-17 |
| BR0013999A (pt) | 2002-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20022180D0 (no) | Hematopoietisk differensiering av humane embryoniske stamceller | |
| IL207268A0 (en) | Methods of culture systems of preparing feeder cells - free, xeno - free human embryonic stem cells and stem cell cultures prepared using same | |
| NO20033396D0 (no) | Forbedret in vitro fremgangsmåte for kultivering av mammale celler for autolog celle implantasjon/transplantasjon fremgangsmåter | |
| IL128348A0 (en) | Embryonic or stem-like cell lines produced by cross species nuclear transplantation | |
| NZ336612A (en) | Cloning using donor nuclei from proliferating somatic cells | |
| MXPA02004333A (es) | Uso de genomas haploides para diagnostico, modificacion y multiplicacion genetica. | |
| PL356025A1 (en) | Sugarbeet regeneration and transformation | |
| NZ513888A (en) | Embryonic or stem-like cell lines produced by cross species nuclear transplantation | |
| EP1385933A4 (en) | CULTURE MEDIUM FOR CELL GROWTH AND CELL TRANSFECTION | |
| PL328922A1 (en) | Culture medium for growing mammal tissue cells | |
| EP1017423A4 (en) | CLONING OF PIGS USING DONOR CORES FROM DIFFERENTIATED CELLS | |
| GB2432846B (en) | Medium and culture of embryonic stem cells | |
| WO2002072762A3 (en) | Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture | |
| EP1123975A4 (en) | THREE-DIMENSIONAL CELL INCUBATION MEDIA AND CELL INCUBATION METHOD USING THE SAME | |
| IL141735A0 (en) | Method of culturing embryonic stem cells | |
| IL138201A0 (en) | Embryonic or stem-like cell lines produced by cross-species nuclear transplantation | |
| PL335723A1 (en) | Hair breeding method | |
| IL148547A (en) | Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions | |
| GB2386905B (en) | Carrier for cell culture and method for culturing cells | |
| WO2001042421A3 (en) | Long-term cell culture compositions and genetically modified animals derived therefrom | |
| EP1240318A4 (en) | EMBRYONAL OR STEM CELL-LIKE CELLS PRODUCED BY CROSS-SPECIES, NUCLEAR TRANSPLANTATION | |
| IL149071A0 (en) | Preparation and selection of donor cells for nuclear transplantation | |
| WO2003100011A3 (en) | Generation of histocompatible tissues using nuclear transplantation | |
| MXPA02001400A (es) | Lineas de celulas blastodermicas de ave. | |
| ATE517990T1 (de) | Effektive kernumprogrammierung in säugetieren |